Another Major Drug Approval for Regeneron
Congratulations to BCW member Regeneron on the approval of an important new drug to help patients with rheumatoid arthritis. The U.S. Food and Drug Administration has approved the human antibody drug sarilumab, developed by Regeneron Pharmaceuticals Inc. in Westchester and its French pharmaceutical partner Sanofi and trademarked as Kevzara, to treat adult patients with moderately to severely active rheumatoid arthritis.
The FDA approval came less than two months after the federal agency approved Regeneron’s and Sanofi’s human antibody dupilumab, marketed as Dupixent, as the first biologic medicine used to treat the debilitating itching and widespread rashes afflicting adults with moderate to severe cases of atopic dermatitis.
Similar News Items
Lights, Camera, Action! The business of TV and film production is booming in Westchester County. According to a new annual economic impact report released by County Executive Ken Jenkins, the county’s film and television sector contributed $924.2 million to the local economy in 2024. Total jobs supported by the County’s film and television industry last […]
The Business Council of Westchester is among 42 business organizations statewide that vehemently oppose the Twenty First Century Anti-Trust bill,(S335/A2015) In a letter to the Governor and Legislature, the coalition urges rejection of the legislation which is both anti-business and anti-consumer and would destroy the state’s economy. “This legislation comes out of a national movement […]
Congratulations to BCW Member White Plains Hospital on the groundbreaking ceremony held Monday for its largest-ever campus transformation project: a 10-story, approximately 500,000-square-foot expansion that will nearly double the size of the hospital when it opens in 2028. Leaders from the hospital were joined by Montefiore Medicine President and CEO Dr. Philip Ozuah, Westchester County […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.